• Simon Lal, Andre Van Gossum, Francisca Joly, Federico Bozzetti, Cristina Cuerda, Georg Lamprecht, Manpreet S Mundi, Michael Staun, Kinga Szczepanek, Geert Wanten, Carolyn Wheatley, Loris Pironi, and Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of the European Society for Clinical Nutrition and Metabolism (ESPEN).
• Intestinal Failure Unit, Salford Royal Foundation Trust and University of Manchester, Manchester, Stott Lane, Salford, M6 8HD, UK. Electronic address: simon.lal@srft.nhs.uk.
• Clin Nutr. 2020 Jul 1; 39 (7): 1988-1991.

AbstractThe management of patients with chronic intestinal failure requiring home parenteral nutrition has been and will continue to be impaired during the SARS-CoV-2 pandemic. Multidisciplinary intestinal failure teams may have to adapt their clinical approaches to home care, outpatient care as well as hospital admission and discharge in order to keep this vulnerable group of patients as safe and well as possible during the unprecedented challenges that countries are facing during the pandemic. Equally, it is important that expert advice from intestinal failure teams is available when home parenteral nutrition (HPN)-dependent patients require admission with SARS-CoV-2 infection. The Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of the European Society for Clinical Nutrition and Metabolism (ESPEN) has developed a position paper to outline areas for intestinal failure teams to consider when managing patients with chronic intestinal failure during the SARS-CoV-2 pandemic.Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

22 keywords...

hide…